HCA Healthcare Overview
HCA Healthcare Target Price
See HCA Healthcare's analyst price targets ($450) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$413.58
Average Target Price
$445.00
7.6% upside
7.6% upside18 analysts in the last 4 months
High: $579 | Low: $369
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-28 | Goldman Sachs | $485 | 17.3% upside |  |
| 2026-07-27 | Robert W. Baird | $393 |  5% downside | |
| 2026-07-27 | Deutsche Bank | $476 | 15.1% upside | |
| 2026-07-27 | Morgan Stanley | $380 | 8.1% downside | |
| 2026-07-27 | OppenheimerMichael Wiederhorn | $485 | 17.3% upside | |
| 2026-07-27 | Barclays | $387 | 6.4% downside | |
| 2026-07-27 | UBS | $579 | 40% upside | |
| 2026-07-27 | KeyBanc | $435 | 5.2% upside | |
| 2026-07-20 | Wells FargoStephen Baxter | $369 | 10.8% downside | |
| 2026-07-16 | Barclays | $402 | 2.8% downside | |
| 2026-07-15 | RBC Capital | $435 | 5.2% upside | |
| 2026-07-14 | Jefferies | $450 | 8.8% upside | |
| 2026-07-13 | Wells Fargo | $428 | 3.5% upside | |
| 2026-07-08 | Barclays | $427 | 3.2% upside | |
| 2026-07-07 | Cantor Fitzgerald | $525 | 26.9% upside | |
| 2026-07-07 | Raymond JamesSarah James | $528 | 27.7% upside | |
| 2026-06-04 | Truist Financial | $413 | 0.1% downside | |
| 2026-06-04 | Bernstein | $413 | 0.1% downside | |
| 2026-04-27 | KeyBanc | $510 | 23.3% upside | |
| 2026-04-27 | Stephens | $530 | 28.1% upside | |
| 2026-04-27 | Barclays | $496 | 19.9% upside | |
| 2026-04-27 | Wells Fargo | $436 | 5.4% upside | |
| 2026-04-27 | RBC Capital | $534 | 29.1% upside | |
| 2026-04-27 | Oppenheimer | $520 | 25.7% upside | |
| 2026-04-27 | Truist Financial | $535 | 29.4% upside | |
| 2026-04-24 | Jefferies | $525 | 26.9% upside | |
| 2026-02-23 | UBS | $635 | 53.5% upside | |
| 2026-02-09 | Bernstein | $541 | 30.8% upside | |
| 2026-02-02 | Mizuho Securities | $540 | 30.6% upside | |
| 2026-01-30 | Wells Fargo | $481 | 16.3% upside | |
| 2026-01-28 | UBS | $598 | 44.6% upside | |
| 2026-01-28 | BarclaysAndrew Mok | $551 | 33.2% upside | |
| 2026-01-28 | KeyBanc | $503 | 21.6% upside | |
| 2026-01-28 | UBS | $588 | 42.2% upside | |
| 2026-01-28 | Oppenheimer | $540 | 30.6% upside | |
| 2026-01-28 | RBC Capital | $555 | 34.2% upside | |
| 2026-01-28 | KeyBanc | $550 | 33% upside | |
| 2026-01-22 | KeyBanc | $500 | 20.9% upside | |
| 2026-01-07 | Wells FargoStephen Baxter | $452 | 9.3% upside | |
| 2026-01-06 | Bernstein | $503 | 21.6% upside | |
| 2025-12-18 | Mizuho Securities | $520 | 25.7% upside | |
| 2025-10-27 | Oppenheimer | $500 | 20.9% upside | |
| 2025-10-27 | Raymond JamesSarah James | $525 | 26.9% upside | |
| 2025-10-27 | Goldman SachsScott Fidel | $520 | 25.7% upside | |
| 2025-10-27 | Morgan Stanley | $425 | 2.8% upside | |
| 2025-10-27 | UBS | $525 | 26.9% upside | |
| 2025-10-27 | Barclays | $494 | 19.4% upside | |
| 2025-10-27 | RBC CapitalBen Hendrix | $482 | 16.5% upside | |
| 2025-10-27 | StephensRaj Kumar | $500 | 20.9% upside | |
| 2025-10-27 | Truist Financial | $495 | 19.7% upside | |